Published in Organogenesis on July 01, 2010
Long noncoding RNAs regulate adipogenesis. Proc Natl Acad Sci U S A (2013) 1.90
Histone demethylase LSD1 regulates adipogenesis. J Biol Chem (2010) 1.50
Additional sex comb-like (ASXL) proteins 1 and 2 play opposite roles in adipogenesis via reciprocal regulation of peroxisome proliferator-activated receptor {gamma}. J Biol Chem (2010) 1.12
Epigenetic codes of PPARγ in metabolic disease. FEBS Lett (2011) 1.04
Epigenetic modifications in the pathogenesis of diabetic nephropathy. Semin Nephrol (2013) 1.02
Microvesicles/exosomes as potential novel biomarkers of metabolic diseases. Diabetes Metab Syndr Obes (2012) 1.01
Epigenetic modification of the leptin promoter in diet-induced obese mice and the effects of N-3 polyunsaturated fatty acids. Sci Rep (2014) 0.89
A mutation in the c-fos gene associated with congenital generalized lipodystrophy. Orphanet J Rare Dis (2013) 0.86
Ascorbic acid is a dose-dependent inhibitor of adipocyte differentiation, probably by reducing cAMP pool. Front Cell Dev Biol (2014) 0.77
The KDM5 family is required for activation of pro-proliferative cell cycle genes during adipocyte differentiation. Nucleic Acids Res (2016) 0.75
Epigenetic programming of Dnmt3a mediated by AP2α is required for granting preadipocyte the ability to differentiate. Cell Death Dis (2016) 0.75
Translating the histone code. Science (2001) 56.77
Chromatin modifications and their function. Cell (2007) 55.98
A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell (2006) 48.80
Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature (2008) 30.29
Brown adipose tissue: function and physiological significance. Physiol Rev (2004) 23.00
Identification and importance of brown adipose tissue in adult humans. N Engl J Med (2009) 20.57
Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature (2001) 19.67
Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell (1997) 18.91
The mammalian epigenome. Cell (2007) 18.13
Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell (1997) 16.78
Active genes are tri-methylated at K4 of histone H3. Nature (2002) 15.68
Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev (2006) 14.36
Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell (1997) 13.53
PRDM16 controls a brown fat/skeletal muscle switch. Nature (2008) 13.08
Chromatin signatures of pluripotent cell lines. Nat Cell Biol (2006) 12.88
Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol (2006) 11.36
Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab (2007) 10.40
Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature (2004) 10.32
PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell (1999) 10.08
PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell (1999) 9.74
Transcriptional control of adipocyte formation. Cell Metab (2006) 9.50
Histone H3 lysine 4 methylation patterns in higher eukaryotic genes. Nat Cell Biol (2003) 8.82
Developmental origin of fat: tracking obesity to its source. Cell (2007) 8.80
Hyperdynamic plasticity of chromatin proteins in pluripotent embryonic stem cells. Dev Cell (2006) 8.53
Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature (1998) 8.33
An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell (1975) 8.29
Epigenetics: a landscape takes shape. Cell (2007) 8.29
Lineage-specific polycomb targets and de novo DNA methylation define restriction and potential of neuronal progenitors. Mol Cell (2008) 7.68
Methylation of histone H3 Lys 4 in coding regions of active genes. Proc Natl Acad Sci U S A (2002) 7.67
New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature (2008) 6.82
Transcriptional control of brown fat determination by PRDM16. Cell Metab (2007) 6.79
C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes Dev (2002) 6.46
Histone methyltransferases direct different degrees of methylation to define distinct chromatin domains. Mol Cell (2003) 6.44
Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr (2004) 6.31
Higher-order structure in pericentric heterochromatin involves a distinct pattern of histone modification and an RNA component. Nat Genet (2002) 5.86
Regulation of bone mass by Wnt signaling. J Clin Invest (2006) 5.59
Mapping global histone acetylation patterns to gene expression. Cell (2004) 5.57
Promoter CpG methylation contributes to ES cell gene regulation in parallel with Oct4/Nanog, PcG complex, and histone H3 K4/K27 trimethylation. Cell Stem Cell (2008) 5.40
Histone trimethylation and the maintenance of transcriptional ON and OFF states by trxG and PcG proteins. Genes Dev (2006) 5.03
Initiation of myoblast to brown fat switch by a PRDM16-C/EBP-beta transcriptional complex. Nature (2009) 4.98
Genome-wide profiling of PPARgamma:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis. Genes Dev (2008) 4.93
PPARgamma and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale. Genes Dev (2008) 4.83
Evidence for a role of developmental genes in the origin of obesity and body fat distribution. Proc Natl Acad Sci U S A (2006) 4.81
PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex. J Biol Chem (2007) 4.79
Myogenic gene expression signature establishes that brown and white adipocytes originate from distinct cell lineages. Proc Natl Acad Sci U S A (2007) 4.69
Spontaneous heritable changes leading to increased adipose conversion in 3T3 cells. Cell (1976) 4.63
Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc Natl Acad Sci U S A (2005) 4.48
DNA methylation and histone modifications: teaming up to silence genes. Curr Opin Genet Dev (2005) 4.25
Retracted A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-gamma transactivation. Nat Cell Biol (2007) 3.97
Regulation of the brown and white fat gene programs through a PRDM16/CtBP transcriptional complex. Genes Dev (2008) 3.90
Nuclear receptor corepressor RIP140 regulates fat accumulation. Proc Natl Acad Sci U S A (2004) 3.67
Retinoblastoma protein functions as a molecular switch determining white versus brown adipocyte differentiation. Proc Natl Acad Sci U S A (2004) 3.45
The adipose organ. Prostaglandins Leukot Essent Fatty Acids (2005) 3.34
Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes. Genes Dev (2005) 3.30
Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors. Proc Natl Acad Sci U S A (1996) 3.24
ES cell pluripotency and germ-layer formation require the SWI/SNF chromatin remodeling component BAF250a. Proc Natl Acad Sci U S A (2008) 3.15
Acquirement of brown fat cell features by human white adipocytes. J Biol Chem (2003) 3.05
MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes (2009) 3.02
Defining the regulatory networks for muscle development. Curr Opin Genet Dev (1996) 2.79
The retinoblastoma-histone deacetylase 3 complex inhibits PPARgamma and adipocyte differentiation. Dev Cell (2002) 2.61
Commitment of C3H10T1/2 pluripotent stem cells to the adipocyte lineage. Proc Natl Acad Sci U S A (2004) 2.56
RIP140-targeted repression of gene expression in adipocytes. Mol Cell Biol (2005) 2.52
Role of Jhdm2a in regulating metabolic gene expression and obesity resistance. Nature (2009) 2.35
A role of miR-27 in the regulation of adipogenesis. FEBS J (2009) 2.27
The spatio-temporal organization of DNA replication sites is identical in primary, immortalized and transformed mammalian cells. J Cell Sci (2002) 2.16
Methylation and expression of the Myo D1 determination gene. Philos Trans R Soc Lond B Biol Sci (1990) 2.06
Cyclin D1 inhibits peroxisome proliferator-activated receptor gamma-mediated adipogenesis through histone deacetylase recruitment. J Biol Chem (2005) 2.01
Temporal recruitment of transcription factors and SWI/SNF chromatin-remodeling enzymes during adipogenic induction of the peroxisome proliferator-activated receptor gamma nuclear hormone receptor. Mol Cell Biol (2004) 2.00
Cooperation between C/EBPalpha TBP/TFIIB and SWI/SNF recruiting domains is required for adipocyte differentiation. Genes Dev (2001) 2.00
The nuclear receptor corepressors NCoR and SMRT decrease peroxisome proliferator-activated receptor gamma transcriptional activity and repress 3T3-L1 adipogenesis. J Biol Chem (2005) 1.99
Transcriptional inhibition of genes with severe histone h3 hypoacetylation in the coding region. Mol Cell (2002) 1.91
MicroRNA expression in human omental and subcutaneous adipose tissue. PLoS One (2009) 1.81
Histone methylation regulator PTIP is required for PPARgamma and C/EBPalpha expression and adipogenesis. Cell Metab (2009) 1.80
Targeted inactivation of MLL3 histone H3-Lys-4 methyltransferase activity in the mouse reveals vital roles for MLL3 in adipogenesis. Proc Natl Acad Sci U S A (2008) 1.80
The peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha heterodimer targets the histone modification enzyme PR-Set7/Setd8 gene and regulates adipogenesis through a positive feedback loop. Mol Cell Biol (2009) 1.78
Down-regulation of histone deacetylases stimulates adipocyte differentiation. J Biol Chem (2006) 1.75
Stable stem cell commitment to the adipocyte lineage by inhibition of DNA methylation: role of the BMP-4 gene. Proc Natl Acad Sci U S A (2006) 1.70
Molecular determinants of brown adipocyte formation and function. Genes Dev (2008) 1.68
Distinct expression of muscle-specific microRNAs (myomirs) in brown adipocytes. J Cell Physiol (2009) 1.67
p300 interacts with the N- and C-terminal part of PPARgamma2 in a ligand-independent and -dependent manner, respectively. J Biol Chem (1999) 1.66
Cyclin D3 promotes adipogenesis through activation of peroxisome proliferator-activated receptor gamma. Mol Cell Biol (2005) 1.63
The generation of adipocytes by the neural crest. Development (2007) 1.53
10T1/2 cells: an in vitro model for molecular genetic analysis of mesodermal determination and differentiation. Environ Health Perspect (1989) 1.52
Expression of the peroxisome proliferator activated receptor gamma gene is repressed by DNA methylation in visceral adipose tissue of mouse models of diabetes. BMC Biol (2009) 1.51
Mesenchymal stem cells: biological characteristics and potential clinical applications. Cloning Stem Cells (2004) 1.49
Stimulation of preadipocyte differentiation by steroid through targeting of an HDAC1 complex. EMBO J (2003) 1.48
Suppression of PPAR transactivation switches cell fate of bone marrow stem cells from adipocytes into osteoblasts. Ann N Y Acad Sci (2007) 1.48
Krüppel-like factor-6 promotes preadipocyte differentiation through histone deacetylase 3-dependent repression of DLK1. J Biol Chem (2005) 1.46
Enhanced leptin-stimulated Pi3k activation in the CNS promotes white adipose tissue transdifferentiation. Cell Metab (2007) 1.39
Biology of regional body fat distribution: relationship to non-insulin-dependent diabetes mellitus. Diabetes Metab Rev (1989) 1.37
Stable CpG hypomethylation of adipogenic promoters in freshly isolated, cultured, and differentiated mesenchymal stem cells from adipose tissue. Mol Biol Cell (2006) 1.36
Histone H3 modifications associated with differentiation and long-term culture of mesenchymal adipose stem cells. Stem Cells Dev (2009) 1.28
Obesity and metabolic syndrome in histone demethylase JHDM2a-deficient mice. Genes Cells (2009) 1.28
The CCAAT enhancer-binding protein alpha (C/EBPalpha) requires a SWI/SNF complex for proliferation arrest. J Biol Chem (2003) 1.26
Temporal recruitment of CCAAT/enhancer-binding proteins to early and late adipogenic promoters in vivo. J Mol Endocrinol (2006) 1.24
Cyclin D3 maintains growth-inhibitory activity of C/EBPalpha by stabilizing C/EBPalpha-cdk2 and C/EBPalpha-Brm complexes. Mol Cell Biol (2006) 1.22
Histone H3 lysine 4 dimethylation signals the transcriptional competence of the adiponectin promoter in preadipocytes. J Biol Chem (2006) 1.21
CARM1 promotes adipocyte differentiation by coactivating PPARgamma. EMBO Rep (2008) 1.21
The spatial repositioning of adipogenesis genes is correlated with their expression status in a porcine mesenchymal stem cell adipogenesis model system. Chromosoma (2009) 1.20
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet (2002) 9.48
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial. Lancet (2009) 8.54
Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA (2003) 8.47
Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine. Diabetes Care (2005) 3.55
Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial. Eur Heart J (2010) 2.68
Mitofusin 2 in POMC neurons connects ER stress with leptin resistance and energy imbalance. Cell (2013) 2.43
Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes. Diabetes Care (2004) 1.75
Identification of a pancreatic stellate cell population with properties of progenitor cells: new role for stellate cells in the pancreas. Biochem J (2009) 1.64
GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects. Obes Surg (2006) 1.60
Histone demethylase LSD1 regulates adipogenesis. J Biol Chem (2010) 1.50
[Organization and functioning model of biomedical research structures. Situation and future challenges]. Med Clin (Barc) (2008) 1.46
Histone H3 lysine 4 dimethylation signals the transcriptional competence of the adiponectin promoter in preadipocytes. J Biol Chem (2006) 1.21
Genetic evidence that HNF-1alpha-dependent transcriptional control of HNF-4alpha is essential for human pancreatic beta cell function. J Clin Invest (2002) 1.16
Induction of pancreatic islet cell differentiation by the neurogenin-neuroD cascade. Differentiation (2007) 1.09
Short-term effects of gastric bypass surgery on circulating ghrelin levels. Obes Res (2004) 1.06
Hypothalamic and brainstem neuronal circuits controlling homeostatic energy balance. J Endocrinol (2014) 1.05
Circulating peptide YY, weight loss, and glucose homeostasis after gastric bypass surgery in morbidly obese subjects. Ann Surg (2008) 1.04
Chromatin and chromatin-modifying proteins in adipogenesis. Biochem Cell Biol (2007) 1.02
Identification of the bHLH factor Math6 as a novel component of the embryonic pancreas transcriptional network. PLoS One (2008) 1.00
Epigenetic regulation of adipogenesis. Curr Opin Clin Nutr Metab Care (2012) 1.00
Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: a randomized controlled trial (the RECORD study). Cardiovasc Diabetol (2008) 0.99
Deletion of miRNA processing enzyme Dicer in POMC-expressing cells leads to pituitary dysfunction, neurodegeneration and development of obesity. Mol Metab (2012) 0.98
Insulin hypersecretion in islets from diet-induced hyperinsulinemic obese female mice is associated with several functional adaptations in individual β-cells. Endocrinology (2013) 0.97
Insulin resistance, inflammation, and the metabolic syndrome following Roux-en-Y gastric bypass surgery in severely obese subjects. Diabetes Care (2007) 0.97
Inhibition of 5-lipoxygenase induces cell growth arrest and apoptosis in rat Kupffer cells: implications for liver fibrosis. FASEB J (2003) 0.97
Involvement of the clock gene Rev-erb alpha in the regulation of glucagon secretion in pancreatic alpha-cells. PLoS One (2013) 0.97
Neurophysiological and epigenetic effects of physical exercise on the aging process. Ageing Res Rev (2011) 0.95
Cyclin-dependent kinase 4 hyperactivity promotes autoreactivity in the immune system but protects pancreatic cell mass from autoimmune destruction in the nonobese diabetic mouse model. J Immunol (2008) 0.94
Development and functional characterization of insulin-releasing human pancreatic beta cell lines produced by electrofusion. J Biol Chem (2011) 0.93
Role of myotonic dystrophy protein kinase (DMPK) in glucose homeostasis and muscle insulin action. PLoS One (2007) 0.92
Insulin glargine-based therapy improves glycemic control in patients with type 2 diabetes sub-optimally controlled on premixed insulin therapies. Diabetes Res Clin Pract (2007) 0.90
Pulsatile insulin release from islets isolated from three subjects with type 2 diabetes. Diabetes (2002) 0.88
Coordinate functional regulation between microsomal prostaglandin E synthase-1 (mPGES-1) and peroxisome proliferator-activated receptor γ (PPARγ) in the conversion of white-to-brown adipocytes. J Biol Chem (2013) 0.88
Diabetes as a case study of chronic disease management with a personalized approach: the role of a structured feedback loop. Diabetes Res Clin Pract (2012) 0.88
Integration of DIGE and bioinformatics analyses reveals a role of the antiobesity agent tungstate in redox and energy homeostasis pathways in brown adipose tissue. Mol Cell Proteomics (2007) 0.87
Prevalence of the metabolic syndrome in Spain using regional cutoff points for waist circumference: the di@bet.es study. Acta Diabetol (2013) 0.85
Melatonin prevents mitochondrial dysfunction and insulin resistance in rat skeletal muscle. J Pineal Res (2014) 0.85
In vivo diabetogenic action of CD4+ T lymphocytes requires Fas expression and is independent of IL-1 and IL-18. Eur J Immunol (2011) 0.85
Long-term exercise modulates hippocampal gene expression in senescent female mice. J Alzheimers Dis (2013) 0.85
Islet amyloid polypeptide gene promoter polymorphisms are not associated with Type 2 diabetes or with the severity of islet amyloidosis. Biochim Biophys Acta (2005) 0.84
Characterization of the transcriptional activity of the basic helix-loop-helix (bHLH) transcription factor Atoh8. Biochim Biophys Acta (2013) 0.84
Targeting type 2 diabetes: lessons from a knockout model of insulin receptor substrate 2. Can J Physiol Pharmacol (2014) 0.84
The antidiabetic agent sodium tungstate activates glycogen synthesis through an insulin receptor-independent pathway. J Biol Chem (2003) 0.84
Tungstate decreases weight gain and adiposity in obese rats through increased thermogenesis and lipid oxidation. Endocrinology (2005) 0.84
Insulin lispro is as effective as regular insulin in optimising metabolic control and preserving beta-cell function at onset of type 1 diabetes mellitus. Diabetes Res Clin Pract (2003) 0.84
Incidence and prevalence of unrecognized myocardial infarction in people with diabetes: a substudy of the Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycemia in Diabetes (RECORD) study. Diabetes Care (2011) 0.83
BACE2 plays a role in the insulin receptor trafficking in pancreatic ß-cells. Am J Physiol Endocrinol Metab (2010) 0.83
In vivo JNK activation in pancreatic β-cells leads to glucose intolerance caused by insulin resistance in pancreas. Diabetes (2013) 0.83
Molecular mechanisms of tungstate-induced pancreatic plasticity: a transcriptomics approach. BMC Genomics (2009) 0.83
Intra-abdominal fat adiponectin receptors expression and cardiovascular metabolic risk factors in obesity and diabetes. Obes Surg (2006) 0.83
Expression of TMEM16A and SLC4A4 in human pancreatic islets. Cell Physiol Biochem (2012) 0.82
The efficiency of telemedicine to optimize metabolic control in patients with type 1 diabetes mellitus: Telemed study. Diabetes Technol Ther (2014) 0.82
Essential pathogenic role of endogenous IL-18 in murine diabetes induced by multiple low doses of streptozotocin. Prevention of hyperglycemia and insulitis by a recombinant IL-18-binding protein: Fc construct. Eur J Immunol (2003) 0.81
Sequence and epigenetic determinants in the regulation of the Math6 gene by Neurogenin3. Differentiation (2011) 0.80
Application of electrophoretic mobility shift assay and chromatin immunoprecipitation in the study of transcription in adipose cells. Methods Mol Biol (2008) 0.80
Phosphorylation events implicating p38 and PI3K mediate tungstate-effects in MIN6 beta cells. Biochem Biophys Res Commun (2007) 0.80
Role of IGFBP-3 in the regulation of β-cell mass during obesity: adipose tissue/β-cell cross talk. Endocrinology (2011) 0.80
Ambient temperature and prevalence of obesity in the Spanish population: The Di@bet.es study. Obesity (Silver Spring) (2014) 0.80
Amylin and hypertension: association of an amylin -G132A gene mutation and hypertension in humans and amylin-induced endothelium dysfunction in rats. J Clin Endocrinol Metab (2007) 0.79
Impaired glucose tolerance: is there a case for pharmacologic intervention? Treat Endocrinol (2002) 0.79
Inhibition of GSK3 dependent tau phosphorylation by metals. Curr Alzheimer Res (2006) 0.79
S 23521 decreases food intake and body weight gain in diet-induced obese rats. Obes Res (2004) 0.79
Sodium tungstate decreases the phosphorylation of tau through GSK3 inactivation. J Neurosci Res (2006) 0.79
Histone demethylase KDM1A represses inflammatory gene expression in preadipocytes. Obesity (Silver Spring) (2013) 0.78
The selective cyclooxygenase-2 inhibitor celecoxib modulates the formation of vasoconstrictor eicosanoids and activates PPARgamma. Influence of albumin. J Hepatol (2005) 0.78
Downregulation of Sfrp5 promotes beta cell proliferation during obesity in the rat. Diabetologia (2013) 0.78
Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 activity exerts an antidiabetic action in Goto-Kakizaki rats. Diabetes (2003) 0.78
Target identification of the novel antiobesity agent tungstate in adipose tissue from obese rats. Proteomics (2005) 0.78
Adult-onset atypical (type 1) diabetes: additional insights and differences with type 1A diabetes in a European Mediterranean population. Diabetes Care (2004) 0.78
Circulating SFRP5 levels are elevated in drug-naïve recently diagnosed type 2 diabetic patients as compared with prediabetic subjects and controls. Diabetes Metab Res Rev (2014) 0.77
Integrative analysis reveals novel pathways mediating the interaction between adipose tissue and pancreatic islets in obesity in rats. Diabetologia (2014) 0.77
Anti-obesity sodium tungstate treatment triggers axonal and glial plasticity in hypothalamic feeding centers. PLoS One (2012) 0.77
A functional leptin system is essential for sodium tungstate antiobesity action. Endocrinology (2008) 0.77
Tungstate promotes β-cell survival in Irs2-/- mice. Am J Physiol Endocrinol Metab (2013) 0.76
Transcript expression of two Iglambda rearrangements and RAG-1/RAG-2 in a mature human B cell producing IgMlambda islet cell autoantibody. J Clin Immunol (2003) 0.76
Altered β-adrenergic response in mice lacking myotonic dystrophy protein kinase. Muscle Nerve (2012) 0.76
The sole presence of CDK4 is not a solid criterion for discriminating between tumor and healthy pancreatic tissues. Int J Cancer (2011) 0.76
Gastric inhibitory polypeptide receptor methylation in newly diagnosed, drug-naïve patients with type 2 diabetes: a case-control study. PLoS One (2013) 0.76
Correction: Slug Is Increased in Vascular Remodeling and Induces a Smooth Muscle Cell Proliferative Phenotype. PLoS One (2016) 0.75
Rcor2 underexpression in senescent mice: a target for inflammaging? J Neuroinflammation (2014) 0.75
Assessing the impact of a new delivery method of insulin on glycemic control using a novel trial design. Diabetes Metab Syndr Obes (2009) 0.75
True anti-anionic phospholipid immunoglobulin M antibodies can exert lupus anticoagulant activity. Br J Haematol (2002) 0.75
[Scientific and technical advances in biomedicine: reflection on clinical management]. Med Clin (Barc) (2008) 0.75
Site-directed mutations in the FAD-binding domain of glycerophosphate dehydrogenase: catalytic defects with preserved mitochondrial anchoring of the enzyme in transfected COS-7 cells. Mol Genet Metab (2002) 0.75